Synthesis of Chiral Cyclophanes
2005 2010
temperature and filtered. The filtrate was poured into aqueous NH4Cl, and
extracted with ethyl acetate. The extract was then washed with brine, dried
over MgSO4, and filtered. The solvent was evaporated in vacuo, and the
residue was purified by chromatography (CH2Cl2/AcOEt 25:1) to give 13
(2.73 g, 77%) as a yellow foam (a mixture of diastereomers). 1H NMR
(500 MHz, CDCl3): d 2.37 (s, 6H), 4.50 4.54 (m, 2H), 4.68 4.74 (m,
2H), 6.27 6.34 (m, 2H), 6.63 6.65 (m, 2H), 6.79 (d, J 6.7 Hz, 2H), 6.94
(t, J 7.6 Hz, 2H), 7.24 (d, J 7.4 Hz, 4H), 7.29 7.34 (m, 8H), 7.45 7.52
(m, 8H), 7.71 (dd, J 8.6, 2.5 Hz, 2H), 7.86 (d, J 7.0 Hz, 2H), 7.87 (d, J
7.4 Hz, 2H), 7.95 (d, J 8.9 Hz, 2H), 7.97 (d, J 8.9 Hz, 2H); 13C NMR
(CHCl3, 8.95 Â 10À6 m): lmax (emax) 240 (1.3 Â 105), 282 (3.4 Â 105), 305
(2.5 Â 105), 332 (8.3 Â 104); CD (c 4.47 Â 10À6 m in CHCl3, 1.0 cm cell):
q À 13.7, De À93.3 (at 279 nm); q 39.6, De 268.3 (at 309 nm); q
À30.6, De À207.8 (at 336 nm).
Preparation of 18 (Scheme 6): BuLi (1.39m in hexane, 0.23 mL, 0.32 mmol)
was added at À788C to
a THF solution (30 mL) of 13 (141.2 mg,
0.15 mmol), and the mixture was stirred for 10 min. A THF solution
(8 mL) of 17 (118 mg, 0.17 mmol) was added dropwise over 30 min. After
15 min, ClP(O)(OEt)2 (0.06 mL, 0.40 mmol) was added at À788C, and the
reaction mixture was stirred at room temperature for 1.5 h. tBuOK
(337 mg, 3.0 mmol) was added at À788C, and the reaction mixture was
stirred at room temperature for 2.5 h. After usual work-up with aqueous
NH4Cl solution and AcOEt, the organic layer was evaporated. The crude
mixture was subjected to column chromatography (hexane/CH2Cl2 1:2) to
give 18 (34.7 mg, 20%) as a yellow foam. 1H NMR (300 MHz, CDCl3): d
6.70 (dd, J 1.1, 7.7 Hz, 4H), 7.04 (t, J 7.7 Hz, 4H), 7.27 7.38 (m, 18H),
7.46 (m, 4H), 7.54 (t, J 7.8 Hz, 4H), 7.88 (d, J 8.4 Hz, 4H) , 7.94 (d,
J 8.1 Hz, 4H), 8.03(d, J 8.4 Hz, 4H); 13C NMR (75 MHz, CDCl3): d
88.47, 88.61, 90.11, 92.36, 121.43, 122.03, 123.64, 126.21, 126.45, 126.61,
126.73, 128.03, 128.06, 128.18, 128.41, 131.18, 131.80, 132.52, 132.97, 134.70,
ꢀ
ꢀ
(125 MHz, CDCl3): d 21.21 (Me), 63.77 (CH2), 90.03 (C ), 90.04 (C ),
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
90.06 (C ), 90.08 (C ), 92.22 (C ), 92.24 (C ), 92.25 (C ), 120.88 (C),
120.95 (C), 123.25 (C), 126.23 (CH), 126.27 (CH), 126.34 (C), 126.46 (CH),
126.54 (CH), 126.62 (CH), 126.67 (CH), 127.69 (CH), 127.75 (CH), 127.87
(CH), 127.94 (CH), 128.01 (CH), 128.26 (CH), 128.81 (CH), 128.97 (CH),
130.43 (CH), 131.59 (CH), 131.62 (CH), 132.21 (C), 132.75 (C), 132.78 (C),
133.70 (CH), 133.75 (CH), 134.12 (CH), 134.26 (C), 140.07 (C),140.10
(C),140.12 (C), 140.14 (C), 140.60 (C), 140.63 (C), 142.50 (C); ESI-MS:
calcd for 940.32; found 940.66 [M] .
Synthesis of 3 with bis(sufoximine) (representative procedure) (Scheme 5):
BuLi (1.39m in hexane, 0.81 mL, 1.13 mmol) was added at À788C to a THF
solution (50 mL) of bis(sulfoximine) 13 (547 mg, 0.51 mmol), and the
mixture was stirred for 5 min. Dialdehyde 2a (286 mg, 0.56 mmol) in THF
(25 mL) was added dropwise over 20 min at this temperature. After an
additional 1 h, ClP(O)(OEt)2 (0.21 mL, 1.41 mmol) was added at À788C
and the mixture was stirred at room temperature for 1 h. After addition of
tBuOK (1.14 g, 10.2 mmol) at À788C, the mixture was stirred at this
temperature for 10 min and, then, at room temperature for 3 h. After usual
work-up with aqueous NH4Cl solution and ethyl acetate, the organic layer
was evaporated. The crude mixture was subjected to column chromatog-
raphy (hexane/CH2Cl2 2:1) to give 3a (170 mg, 35%) as a pale yellow foam.
1H NMR (500 MHz, CDCl3): d 6.73 (d, J 7.7 Hz, 4H), 7.05 (t, J 7.7 Hz,
4H), 7.25 (d, J 8.0 Hz, 4H), 7.27 (d, J 7.7 Hz, 4H), 7.31 (t, J 7.7 Hz,
4H), 7.47 (t, J 8.0 Hz, 4H), 7.49 (s, 4H), 7.83 (d, J 8.6 Hz, 4H), 7.92 (d,
J 8.0 Hz, 4H), 7.96 (d, J 8.6 Hz, 4H); 13C NMR (125 MHz, CDCl3): d
136.31, 140.18, 143.35; ESI-MS: calcd for 1155.4; found 1155.4 [MH] ;
[a]2D9:3 À58.80 (c 1.000, CHCl3); [M]D À679.3; UV/Vis (CHCl3,
8.74 Â 10À5 m): lmax (emax) 245 (1.1 Â 105), 281 (2.4 Â 105), 313 (1.5 Â 105);
CD (c 8.74 Â 10À5 m in CHCl3, 0.1 cm cell): q À29.0, De À100.4 (at
281 nm); q 59.2, De 205.4 (at 310 nm); q À34.5, De À119.5 (at
337 nm).
Preparation of 19: A 100 mL flaskwas charged with 12 (1.66 g, 3.30 mmol),
16 (3.53 g, 6.93 mmol), [Pd(Ph3P)4] (191 mg, 0.17 mmol), CuI (32 mg,
0.17 mmol), diisopropylamine (10 mL) and toluene (50 mL). After being
stirred at 708C for 2 h, the reaction mixture was cooled to room
temperature and filtered. The filtrate was poured into aqueous NH4Cl,
and extracted with ethyl acetate. The extract was then washed with brine,
dried over MgSO4, and filtered. The solvent was evaporated in vacuo, and
the residue was chromatographed (CH2Cl2/AcOEt 25:1) to give 19 (2.56 g,
68%) as a yellow foam (a mixture of inseparable diastereomers). 1H NMR
(500 MHz, CDCl3):[16] d 2.36 (s, 6H), 4.74, 4.88 (JAB 13.9 Hz, 4H),
6.65 8.05 (m, 46H); 13C NMR (75 MHz, CDCl3) d 21.35, 63.99, 88.39,
89.29, 90.05, 92.53, 121.18, 122.56, 123.33, 123.42, 126.45, 126.61, 126.79,
126.90, 128.00, 128.01, 128.06, 128.54, 128.60, 129.07, 129.14, 130.75, 131.05,
131.10, 132.22, 132.42, 132.95, 134.03, 134.19, 134.36, 134.50, 140.33, 140.66,
ꢀ
ꢀ
ꢀ
89.14 (4C ), 89.74 (4C ), 92.07 (4C ), 121.45 (4C), 122.96 (4C), 123.58
(4C), 126.42 (4CH), 126.49 (4CH), 126.74 (4CH), 128.04 (4CH), 128.07
(4CH), 128.13 (4CH), 128.39 (4CH), 130.56 (4CH), 130.89 (4CH), 132.49
(4C), 132.96 (4C), 134.86 (4CH), 139.95 (4C); MALDI-MS: calcd for
952.3; found 952.8 [M] ; [a]D29:2 81.2 (c 0.995, CHCl3); [M]D 773.9;
UV/Vis (CHCl3, 4.5 Â 10À6 m): lmax (emax) 239 (1.0 Â 105), 281 (1.7 Â 105),
305 (1.1 Â 104), 331 (5.0 Â 104); CD (c 7.9 Â 10À5 m in CHCl3, 0.1 cm cell):
q À57.3, De À218.7 (at 282 nm); q 69.8, De 266.3 (at 308 nm); q
À29.5, De À112.5 (at 337 nm).
142.70; ESI-MS: calcd for 713.2; found 713.9 [MH] .
Preparation of 3c with sulfoximine 19 (Scheme 7): BuLi (1.39m in hexane,
0.43 mL, 0.60 mmol) was added at À788C to a THF solution (50 mL) of 19
(285 mg, 0.25 mmol), and the mixture was stirred for 15 min. Dialdehyde
2b (196 mg, 0.28 mmol) in THF (20 mL) was added dropwise over 40 min
at this temperature with stirring. After 15 min, ClP(O)(OEt)2 (0.10 mL,
0.69 mmol) was added at À788C and the mixture was stirred at room
temperature for 2.5 h. To this mixture was added tBuOK (337 mg,
3.0 mmol) at À788C and the mixture was stirred at room temperature
for overnight. After usual work-up with aqueous NH4Cl solution and
AcOEt, the organic layer was evaporated. The crude mixture was subjected
to column chromatography (hexane/CH2Cl2 2:1) to give 3c (103 mg, 30%).
1H NMR (500 MHz, CDCl3): d 6.68 (d, J 7.8 Hz, 4H), 7.00 (s, 4H), 7.07
(t, J 7.8 Hz, 4H), 7.28 (d, J 7.7 Hz, 4H), 7.30 7.36 (m, 12H), 7.46 (d, J
7.7 Hz, 4H), 7.49 7.52 (m, 8H), 7.71 (s, 4H), 7.78 (d, J 8.6 Hz, 4H), 7.98
(d, J 8.6 Hz, 4H), 8.00 (d, J 8.6 Hz, 4H); 13C NMR (125 MHz, CDCl3):
The similar treatment of 13 (547 mg, 0.51 mmol) with 2b (398 mg,
0.56 mmol) or 2d (622 mg, 0.56 mmol) furnished 3b (165 mg, 28%) or 3d
(246 mg, 31%), respectively. 3b: 1H NMR (500 MHz, CDCl3): d 6.65 (d,
J 7.6 Hz, 4H), 7.04 (t, J 7.8 Hz, 4H), 7.12 (s, 4H), 7.26 7.35 (m, 14H),
7.43 (d, J 8.3 Hz, 4H), 7.46 (t, J 7.5 Hz, 4H), 7.70 (s, 2H), 7.84 (d, J
8.3 Hz, 4H), 7.94 (d, J 8.0 Hz, 4H), 8.01 (d, J 8.6 Hz, 4H); 13C NMR
ꢀ
ꢀ
ꢀ
(125 MHz, CDCl3): d 88.78 (4C ), 89.19 (4C ), 90.12 (4C ), 92.68
ꢀ
(4C ), 121.45 (4C), 122.85 (4C), 123.38 (4C), 123.50 (4C), 126.47 (4CH),
126.62 (4CH), 126.84 (4CH), 128.05 (4CH), 128.09 (8CH), 128.13 (4CH),
128.46 (2CH), 130.80 (4CH), 131.08 (4CH), 131.25 (4CH), 132.58 (4C),
132.98 (4C), 134.42 (4CH), 134.68 (2CH), 140.41 (4C); MALDI-MS: calcd
for 1152.4; found 1151.2 [M] ; [a]2D8:1 9.2 (c 1.000, CHCl3); [M]D
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
106.1; UV/Vis (CHCl3, 4.5 Â 10À6 m): lmax (emax) 245 (1.1 Â 105), 281
(2.6 Â 105), 305 (1.6 Â 105), 332 (8.7 Â 104); CD (c 9.19 Â 10À6 m in CHCl3,
1.0 cm cell): q À47.7, De À157.3 (at 280 nm); q 82.4, De 271.5 (at
310 nm); q À42.9, De À141.8 (at 336 nm); 3d: 1H NMR (500 MHz,
CDCl3): d 6.67 (d, J 7.8 Hz, 4H), 7.02 (s, 4H), 7.06 (t, J 7.8 Hz, 4H),
7.28 (d, J 8.0 Hz, 4H), 7.31 7.37 (m, 14H), 7.45 7.52 (m, 16H), 7.70 (s,
d 88.77 (4C ), 89.15 (4C ), 89.28 (4C ), 90.09 (4C ), 92.64 (4C ),
121.44 (4C), 122.87 (4C), 123.36 (4C), 123.49 (4C), 123.54 (4C), 126.60
(4CH), 126.63 (4CH), 126.85 (4CH), 128.05 (4CH), 128.09 (8CH), 128.15
(4CH), 128.53 (4CH), 130.79 (4CH), 131.05 (4CH), 131.37 (8CH), 132.58
(4C), 133.06 (4C), 134.47 (4CH), 134.71 (4CH), 140.40 (4C); MALDI-MS:
calcd for 1352.4; found 1351.0 [M] : [a]2D9:2 À70.47 (c 0.990, CHCl3);
[M]D À953.9; UV/Vis (CHCl3, 7.83 Â 10À5 m): lmax (emax) 246 (1.3 Â 104),
282 (3.1 Â 105), 305 (2.2 Â 105), 332 (8.8 Â 104); CD (c 7.8 Â 10À5 m in
CHCl3, 0.1 cm cell): q À19.6, De À76.7 (at 281 nm); q 65.5, De
255.6 (at 310 nm); q À48.9, De À191.0 (at 338 nm).
4H), 7.74 (s, 2H), 7.80 (d, J 8.6 Hz, 4H), 7.98 (d, J 8.0 Hz, 4H), 8.01 (d,
13
ꢀ
J 8.6 Hz, 4H); C NMR (125 MHz, CDCl3): d 88.76 (4C ), 89.14
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
(4C ), 89.17 (4C ), 89.24 (4C ), 90.07 (4C ), 92.64 (4C ), 121.42 (4C),
122.85 (4C), 123.32 (4C), 123.36 (4C), 123.43 (4C), 123.50 (4C), 126.57
(4CH), 126.64 (4CH), 126.85 (4CH), 128.06 (4CH), 128.10 (8CH), 128.14
(4CH), 128.52 (4CH), 128.55 (2CH), 130.81 (4CH), 131.07 (4CH), 131.36
(8CH), 131.45 (4CH), 132.56 (4C), 133.03 (4C), 134.40 (4CH), 134.70
(4CH), 134.74 (2CH), 140.38 (4C); MS (MALDI): calcd for 1552.5; found
Reaction between 12 and 20 (Scheme 8): A two-necked flask was charged
with [Pd(Ph3P)4] (40 mg, 35 mmol), CuI (7 mg, 35 mmol), diisopropylamine
(2 mL), and toluene (10 mL). Then, to the above suspension was added a
solution of 12 (174 mg, 0.35 mmol) and 20 (245 mg, 0.35 mmol) in
diisopropylamine (10 mL) and toluene (50 mL) at 758C by a syringe pump
1553.0 [M] ; [a]2D9:8 À69.22 (c 0.795, CHCl3); [M]D À1075.56; UV/Vis
Chem. Eur. J. 2002, 8, No. 9
¹ WILEY-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002
0947-6539/02/0809-2009 $ 20.00+.50/0
2009